Posted by Michael Wonder on 22 May 2022
‘It’s scary, the thought of not having access’: new anti-depressant considered for PBS
22 May 2022 - A drug described as a last option for people with treatment-resistant depression, which psychiatrists say is unaffordable for almost all patients who need it, could soon be listed on the Pharmaceutical Benefits Scheme.
The Pharmaceutical Benefits Advisory Council (Committee) is seeking submissions from people with major depressive disorder, their carers and health care professionals as it assesses whether to add the first new anti-depressant treatment in more than three decades to the PBS.
